Publications by authors named "Asmaa Al-Tawari"
Article Synopsis
- The text refers to a correction made to a scholarly article identified by the DOI 10.3389/fonc.2024.1323176.
- The correction likely addresses inaccuracies or errors in the original publication.
- Such corrections are important for maintaining the integrity of academic research and ensuring that readers have access to accurate information.
Article Synopsis
- - Neurofibromatosis type 1 (NF1) is a genetic disorder that requires long-term monitoring due to its complex symptoms, which can greatly impact patients' quality of life and create economic challenges for families.
- - The introduction of MEK inhibitors like selumetinib has improved treatment options for NF1-related plexiform neurofibromas, but effective care depends on early detection of the disorder.
- - Experts in the Arabian Gulf region recommend better diagnosis, management strategies, and the establishment of NF1 centers to enhance patient care and outcomes, along with affordable genetic testing.
Despite the availability of international recommendations for the management of Infantile Epileptic Spasms Syndrome (IESS), there is a lack of recommendations adapted to the local context of clinical practice of pediatric neurology in the Gulf Cooperation Council (GCC) countries. By an initiative from the Saudi Pediatric Neurology Society (SPNS), a literature review was performed and an expert panel comprised of 13 pediatric neurologists from all GCC countries (Saudi Arabia, Kuwait, Bahrain, Oman, Qatar, and the United Arab Emirates) was subsequently convened to discuss all issues related to the management and diagnosis practices of IESS in the GCC. The overall aim of this consensus document was to develop practical recommendations to support the care of patients with IESS in the GCC and to reflect on how clinical management approaches compare with those adopted internationally.
View Article and Find Full Text PDFBackground: Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder which leads to progressive muscle degeneration and weakness. Most patients die from cardiac or respiratory failure. Gene transfer therapy offers a promising approach to treating this disorder.
View Article and Find Full Text PDFThe timely and accurate genetic diagnosis of Duchenne muscular dystrophy (DMD) enables prompt initiation of disease management and genetic counseling and optimal patient care. Despite the existence of best practice guidelines for the diagnosis of DMD, implementation of these recommendations in different parts of the world is challenging. Here, we present 4 unique case studies which illustrate the different diagnostic pathways of patients with DMD in Middle Eastern countries and highlight region-specific challenges to achieving timely and accurate genetic diagnosis of DMD.
View Article and Find Full Text PDF